Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04584684 · ClinicalTrials.gov registry record · Phase 2
Mouth Rinses for Inactivation of COVID-19
A Phase 2 study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- Phase 2
- Development phase
- 128
- Enrollment target
NCT04584684 is a Phase 2 study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 128 participants.
The verdict
NCT04584684, a Phase 2 study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 128 participants
- Enrollment target
Study Summary
Randomized, double-blind prospective trial to test the efficacy and acceptability of therapeutic, antiseptic mouth rinses to inactivate severe acute respiratory syndrome coronavirus (SARS-CoV-2) in saliva of COVID-19 positive patients aged 18-65 years old. All mouthrinses are commercially available and will be used according to on-label instructions. Patients will be randomized to a mouthrinse and will be asked to give a saliva sample immediately before and after a one minute mouthwash. Saliva samples will be collected from patients at 15 minute intervals thereafter up to an hour (15, 30, 45 and 60 minutes). The samples will be stored and used for real-time reverse transcription polymerase chain reaction (RT-PCR) detection of viral SARS-CoV-2 RNA and viral infectivity assays. Patients will also complete a short-survey on the taste and experience of using the mouthwash. This study involves 480 subject participants and one, 75-90 minute visit.
Interventions
- OTHER 0.9% w/v NaCL Saline
- DRUG 1.5% w/v Hydrogen Peroxide
- DRUG 0.12% Chlorohexidine Gluconate
- DRUG 27% Ethanol plus essential oils
- DRUG 0.5% w/v Povidone-iodide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2020-12-18 |
| Est. Completion | 2021-10-21 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04584684
The ClinicalTrials.gov registry entry for NCT04584684 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which 0.9% w/v NaCL Saline is the first listed.
NCT04584684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04584684 about?
NCT04584684 is a clinical study titled "Mouth Rinses for Inactivation of COVID-19". Randomized, double-blind prospective trial to test the efficacy and acceptability of therapeutic, antiseptic mouth rinses to inactivate severe acute respiratory syndrome coronavirus (SARS-CoV-2) in saliva of COVID-19 positive patients aged 18-65 years old. All mouthrinses are commercially available ...
What is the current status of trial NCT04584684?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 128 participants. The study started on 2020-12-18. Estimated completion is 2021-10-21.
What interventions are being tested in trial NCT04584684?
The interventions under investigation include: 0.9% w/v NaCL Saline (OTHER), 1.5% w/v Hydrogen Peroxide (DRUG), 0.12% Chlorohexidine Gluconate (DRUG), 27% Ethanol plus essential oils (DRUG), 0.5% w/v Povidone-iodide (DRUG).
Who is sponsoring clinical trial NCT04584684?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.